Trials
Search / Trial NCT05650697

CBD Effects on Forehead Split Scar Healing

Launched by UNIVERSITY OF OKLAHOMA · Dec 6, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Not yet recruiting

Keywords

Paramedian Forehead Flap (Pmff) Cannabidiol (Cbd) Oil Split Scar

ClinConnect Summary

This is a perspective study of 10 adult patients who have undergone nasal reconstructive surgery and had a paramedian forehead flaps. Pictures will be taken, during treatment, of the scar. Silicone ointment will be administered on the first half of the scar and cannabidiol (CBD) oil + silicone ointment on the second half. Participants will be asked to complete a questionnaire at their follow-up clinic visits. Additional data will also be collected: Age, BMI, Medical history with specific interest in conditions which may affect wound healing (Diabetes, immunosuppression, etc), Smoking histor...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patients that are adults (18+) of all genders and ethnicities who have undergone a PMFF will be considered for this study.
  • Exclusion Criteria:
  • • 1. Patients younger than 18 years of age
  • • 2. Patients with known allergies to CBD Provide early termination criteria. There will be immediate termination from the study if any allergic response to the CBD/silicone combination occurs or if the topical application of CBD/silicone significantly worsens the scar outcome at the Follow Up 2 visit or at any subsequent visit or if the patient voluntarily requests cessation in the study.

Trial Officials

Mark Mims, MD

Principal Investigator

University of Oklahoma

About University Of Oklahoma

The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials